IBRANCE
IBRANCE
Discontinued
DIN Number
02453177
Drug Class
Human
Market Date
Apr 19, 2016
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02453177
AIG Number0157970003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EF01 PALBOCICLIB
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PALBOCICLIBActive
Strength: 125 MG
Monograph: PALBOCICLIB